Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects Toxics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06605833
What this trial is testing

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

Who this might be right for
Melanoma Stage III or IV
Royal Marsden NHS Foundation Trust 60
Early research (Phase 1)Study completedNCT00030615
What this trial is testing

Decitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Bladder CancerRecurrent Breast Cancer+6 more
National Cancer Institute (NCI) 24
Not applicableNot Yet RecruitingNCT06518200
What this trial is testing

Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support

Who this might be right for
Breast Cancer Female
Universidad de Granada 102
Not applicableStudy completedNCT02725840
What this trial is testing

Breast Cancer Lung Late Effects

Who this might be right for
Radiation InjuryBreast Cancer
University of Florida 41
Testing effectiveness (Phase 2)WithdrawnNCT01256489
What this trial is testing

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Who this might be right for
Stevens-Johnson SyndromeCorneal Blindness
Massachusetts Eye and Ear Infirmary
Testing effectiveness (Phase 2)Study completedNCT00387374
What this trial is testing

Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab

Who this might be right for
Adenosquamous Cell Lung CancerDrug/Agent Toxicity by Tissue/OrganHemoptysis+3 more
National Cancer Institute (NCI) 72
Post-approval studies (Phase 4)Study completedNCT03823768
What this trial is testing

Envarsus Neurotoxicity Burden in Liver Transplant Patients

Who this might be right for
NeurotoxicityLiver Transplant; Complications
Medical University of South Carolina 30
Not applicableStudy completedNCT03280368
What this trial is testing

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationMedication AdherenceBlood Coagulation Tests+10 more
Hospitalsenheden Vest 430
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Post-approval studies (Phase 4)Study completedNCT02696707
What this trial is testing

An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 200
Not applicableStudy completedNCT03939507
What this trial is testing

Outcome Study in Refractory Epilepsy (SOPHIE)

Who this might be right for
Epilepsy
University of Pavia 1,000
Not applicableUnknownNCT01285674
What this trial is testing

Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

Who this might be right for
CisplatinOtotoxicityIntratympanic Steroids
Ziv Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00055718
What this trial is testing

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Herbert Irving Comprehensive Cancer Center 50
Not applicableLooking for participantsNCT05885048
What this trial is testing

Impact of Gonadotoxic Therapies on Fertility

Who this might be right for
CancerFertility IssuesFertility Preservation+3 more
Michael von Wolff 7,000
Early research (Phase 1)WithdrawnNCT03010995
What this trial is testing

The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study

Who this might be right for
Cigarette Smoking ToxicityNicotineAcute Cardiovascular Disease
University of Louisville
Not applicableUnknownNCT03586401
What this trial is testing

Creating a Decision Support System for the Corporate Management of Physical Therapy

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Brain TumorPhysical Activity+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 1,000
Early research (Phase 1)Study completedNCT00093353
What this trial is testing

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Who this might be right for
DiarrheaDrug/Agent Toxicity by Tissue/OrganNeuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 30
Not applicableStudy completedNCT06012253
What this trial is testing

The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life

Who this might be right for
Chemotherapeutic Toxicity
Akdeniz University Hospital 88
Testing effectiveness (Phase 2)Study completedNCT00003811
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorDrug/Agent Toxicity by Tissue/OrganExtragonadal Germ Cell Tumor+1 more
Children's Oncology Group 27
Post-approval studies (Phase 4)Study completedNCT06139952
What this trial is testing

Ameliorating Contrast Induced Nephropathy After Coronary Angiography

Who this might be right for
Coronary Artery DiseaseNephropathy; Toxic, Drugs
Ain Shams University 120
Next Page